PMID: 7682896

Teem JL, Berger HA, Ostedgaard LS, Rich DP, Tsui LC, Welsh MJ
Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast.
Cell. 1993 Apr 23;73(2):335-46., [PubMed]
Sentences
No. Mutations Sentence Comment
4 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:4:53
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:4:43
status: NEW
view ABCC7 p.Arg553Met details
We isolated two AF508 revertant mutations (R553M and R553Q) that restored mating; both were located within the CFTR NBDl sequence. Login to comment
91 ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:91:160
status: NEW
view ABCC7 p.Arg553Met details
These yeast transformants each contained an H5-AF508 plasmid with a mutation at amino acid R553 of CFTR; in one case, R553 was replaced by methionine (H5-AF508/R553M), and in the other plasmid, R553 was replaced by glutamine (H5-AF508IR553Q). Login to comment
92 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:92:175
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:92:185
status: NEW
view ABCC7 p.Arg553Met details
It is possible that other mutations within the R553-L558 region of the H5-AF508 plasmid could also result in increased mating efficiency; however, we proceeded to analyze the R553Q and R553M mutants in greater detail without further mutagenesis of the R553-L558 region. Login to comment
94 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:94:129
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:94:148
status: NEW
view ABCC7 p.Arg553Met details
Whereas the mating efficiency of the H5-AF508 yeast strain is approximately lo/a of the H5 strain, yeast containing the H5-AF508/R553Q and H5-AF508/R553M plasmids mated at 3% and 3204 respec- 330 tively. Login to comment
96 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:96:28
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:96:38
status: NEW
view ABCC7 p.Arg553Met details
However, when the mutations R553Q and R553M press the AF508 mating defect. Login to comment
97 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:97:61
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:97:4
status: NEW
view ABCC7 p.Arg553Met details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:97:139
status: NEW
view ABCC7 p.Arg553Met details
The R553M mutation were introduced into CFTRAF508 (CFTRAF508/R553Q alone had little effect on H5 (H5R553M); when this mutant and CFTRAF508/R553M, respectively), CAMP-dependent was transformed into yeast, no further increase in mating anion permeability was restored. Login to comment
101 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:101:4
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:101:14
status: NEW
view ABCC7 p.Arg553Met details
The R553Q and R553M mutations partially correct the defect in the H5-AF508 chimera and should also correct the defect in CFTRAF508 if a similar structure exists for NBDl in both proteins. Login to comment
102 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:102:48
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:102:58
status: NEW
view ABCC7 p.Arg553Met details
As a test of this hypothesis, we introduced the R553Q and R553M mutations into CFTRAF508 cDNA and transfected mammalian cells with these constructs to determine whether the revertant mutations would correct the defect in CAMP-regulated Cl- transport of CFTRAF508. Login to comment
105 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:105:107
status: NEW
view ABCC7 p.Arg553Gln details
First, the initial rate of halide efflux after CAMP stimulation was less for CFTRAF508IR553M and CFTRAF508/R553Q than for wild-type CFTR (Figure 3). Login to comment
108 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:108:56
status: NEW
view ABCC7 p.Arg553Gln details
Thus, CAMP-stimulated halide efflux from the CFTRAF5081 R553Q- and CFTRAF508/R553Mtransfected cells was less efficient than that in cells transfected with wild-type CFTR.ThisobservationsuggeststhattheAF508CI-channel defect was only partially reversed by the reversion mutations. Login to comment
109 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:109:0
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:109:92
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:109:10
status: NEW
view ABCC7 p.Arg553Met details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:109:102
status: NEW
view ABCC7 p.Arg553Met details
R553Q and R553M Suppress the CFTRAF508 Anion Transport Defect We assessed the effect of the R553Q and R553M mutations on CFTR function by assaying for CAMP-stimulated halide efflux using the halide-sensitive fluorophore 8-methoxy-N-(3sulfopropyl)-quinolinium (SPQ) (Illsley and Verkman, 1987). Login to comment
110 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:110:46
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:110:59
status: NEW
view ABCC7 p.Arg553Met details
Expression of CFTR cDNA containing either the R553Q or the R553M mutation alone (without the AF508 mutation) in HeLa cells generated CAMP-stimulated halide efflux like wild-type CFTR (Figure 3). Login to comment
112 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:112:87
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:112:73
status: NEW
view ABCC7 p.Arg553Met details
Relative Mating Efficiency of AF5OS Revertants Genotype H5R553M H5-AF508/R553M H&AF508/R553Q HSAF508 Mating Efficiency Relative to H5 (%) 77.4 f 3.7 34.2 f 7.0 3.2 i 0.8 1.1 f 0.5 Mating efficiencies were determined by quantitative mating assays and are expressed as a percentage relative to H5 (100%). Login to comment
118 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:118:93
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:118:94
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:118:103
status: NEW
view ABCC7 p.Arg553Met details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:118:104
status: NEW
view ABCC7 p.Arg553Met details
Correction of CFTRAF508 Processing and Localization Cl- transport by CFTRAF508 containing the R553Q and R553M mutations would be detected only if the processing defect of CFTRAF508 was suppressed. Login to comment
122 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:122:132
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:122:100
status: NEW
view ABCC7 p.Arg553Met details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:122:110
status: NEW
view ABCC7 p.Arg553Met details
CFTRAF508 is only present as the unglycosylated band A and the core glycosyl- 6000 -CFTR - AF508/R553M -c- R553M + AF508lR553Q I R553Q ,+ AF508 0 0 2 4 6 6 10 12 TIME (MIN) ated band B protein, consistent with its failure to traverse the Golgi complex and reach the plasma membrane (Cheng et al., 1990) (Figure 4). Login to comment
124 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:124:103
status: NEW
view ABCC7 p.Arg553Gln details
Analysis of Processed Forms of CFTR (A) Expression of wild-type CFTR (lane I), CFlWR553M (lane 2) CFTR/R553Q (lane 3) and CFTRAF508 (lane 4) in HeLa cells. Login to comment
130 ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:130:68
status: NEW
view ABCC7 p.Arg553Met details
(B) Expression of wild-type CFTR (lane 1) or CFTR mutants CFTRAF508/R553M (lane 2) CFTRAF508IR553Q (lane 3) and CFTRAF508 (lane 4) in HeLa cells. Login to comment
140 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:140:0
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:140:10
status: NEW
view ABCC7 p.Arg553Met details
R553Q and R553M mutations alone (without the AF508 mutation). Login to comment
141 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:141:128
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:141:137
status: NEW
view ABCC7 p.Arg553Met details
As shown in Figure 4A, band C is present in cells expressing wild-type CFTR (lane 1) and also mutant CFTR containing either the R553Q or R553M mutation (lanes 2 and 3). Login to comment
143 ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:143:20
status: NEW
view ABCC7 p.Arg553Met details
Thus, the R5530 and R553M mutationsalone do not affect the glycosylation of CFTR. Login to comment
144 ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:144:40
status: NEW
view ABCC7 p.Arg553Met details
In cells transfected with the CFTRAF508/R553M (Figure 48, lane 2) a small increase in band C is detectable as compared with CFTRAF508 (lane 4). Login to comment
146 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:146:82
status: NEW
view ABCC7 p.Arg553Gln details
We were not able to consistently detect band C CFTR in cells expressing CFTRAF508/R553Q, possibly owing to limitation8 in the sensitivity of the assay. Login to comment
147 ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:147:65
status: NEW
view ABCC7 p.Arg553Met details
Thus, a detectable increase in band C occurs only with CFTRAF508/R553M as compared with CFTRAF508. Login to comment
148 ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:148:58
status: NEW
view ABCC7 p.Arg553Met details
However, the total amount of fully glycosylated CFTRAF508/R553M is still small relative to wild-type CFfR. Login to comment
153 ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:153:41
status: NEW
view ABCC7 p.Arg553Met details
However, when cells expressed CFTRAF508/ R553M, CFTR was detected at the plasma membrane (Figure 5C). Login to comment
154 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:154:14
status: NEW
view ABCC7 p.Arg553Gln details
For CFTRAF508/R553Q, plasma membrane staining of CFTR was weak and variable and could not be demonstrated consistently (Figure 5D). Login to comment
156 ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:156:71
status: NEW
view ABCC7 p.Arg553Met details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:156:274
status: NEW
view ABCC7 p.Arg553Met details
These results are consistent with the observation that more CFTRAF5081 R553M than CFTRAF508Kt553Q is found in the band C Figure 5. lmmunolocalization of Wild-Type and Mutant CFTR HeLa cells were transfected with wild-type CFTR (A) and CFTR mutants CFTRAF508 (B), CFTRAF508/R553M (C), and CFTRAF5081R553Q (D). Login to comment
160 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:160:46
status: NEW
view ABCC7 p.Arg553Gln details
form and suggest that the amount of CFTRAF508/R553Q Single-Channel Analysis of at the plasma membrane is exceedingly low. Login to comment
161 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:161:22
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:161:71
status: NEW
view ABCC7 p.Arg553Met details
Thus, these CFTRAF508/R553Q CFTR data indicate that only the CFTRAF508/R553M mutant is To determine whether the suppressor mutations altered detectable in the plasma membrane at levels greater than the single-channel properties of CFTRAF508, the re- that observed for CFTRAF508. Login to comment
162 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:162:25
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:162:53
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:162:67
status: NEW
view ABCC7 p.Arg553Gln details
vertant mutant CFTRAF508/R553Q was expressed in A R553Q c AF508/R553Q Y---M W---I w---m m--k w----m m-----v w---w 60mV 4OmV 20mV OmV -20 mV -40 mV -60 mV -60 mV -100 mV -120 mV 1P d 1 .4ms Figure 6. Login to comment
174 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:174:13
status: NEW
view ABCC7 p.Arg553Gln details
We chose the R553Q mutant because, as discussed below, it has been observed in a CF patient. Login to comment
185 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:185:85
status: NEW
view ABCC7 p.Arg553Gln details
The results also indicate that, as predicted by the functional analysis of CFTRAF508/R553Q by the SPQ halide efflux assay above, at least some CFTRAF508/R5530 is localized in the plasma membrane. Login to comment
186 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:186:87
status: NEW
view ABCC7 p.Arg553Gln details
Following activation with PKA and ATP, we measured the P, for CFfRIR553Q and CFTRAF508/R553Q at different MgATP concentrations. Login to comment
187 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:187:176
status: NEW
view ABCC7 p.Arg553Gln details
Figures 7A and 78 show examples of the activity of single channels at different concentrations of MgATP; as the concentration of MgATP increased, both CFTRIR553Q and CFTRAF508/R553Q spent more time in the open state. Login to comment
188 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:188:138
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:188:140
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:188:152
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:188:154
status: NEW
view ABCC7 p.Arg553Gln details
Figure 7C shows that the P, of CFTRIR553Q Cl- channels was similar to that previously reported for wild-type CFTR Cl- channels (An- Cdl A R553Q B AF508/R553Q Figure 7. Login to comment
193 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:193:58
status: NEW
view ABCC7 p.Arg553Gln details
A single CFTWR553Q Cl-channel (A) and a single CFTFtAF506/R553Q Cl-channel (6) are shown at different MgATP concentrations. Login to comment
198 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:198:10
status: NEW
view ABCC7 p.Arg553Gln details
Thus, the R553Q mutation corrected the functional defect in gating of the CFTRAF508 Cl- channels. Login to comment
208 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:208:13
status: NEW
view ABCC7 p.Arg553Gln details
Although the R553Q revertant was less eff icient at correcting processing of CFTRAF508 as measured by the amount of fully processed CFTR present and by immunocytochemistry, it produced functional channels as measured by the SPQ halide efflux assay. Login to comment
209 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:209:13
status: NEW
view ABCC7 p.Arg553Gln details
In addition, R553Q corrected the altered gating of CFTRAF508. Login to comment
213 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:213:22
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:213:84
status: NEW
view ABCC7 p.Arg553Gln details
We speculate that the R553Q mutation must change the conformation of the CFTRAF5081 R553Q protein sufficiently to revert gating to normal and that both CFTRAF508lR553Q and CFTRAF508lR553M must adopt a conformation that allows at least some of the mutant protein to escape the cellular quality control mechanisms. Login to comment
215 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:215:34
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:215:44
status: NEW
view ABCC7 p.Arg553Met details
The CFTRAF508 revertant mutations R553Q and R553M were initially identified as revertants of the mating defect in yeast containing the H5-AF508 chimera, suggesting that the structure of NBDl in the chimera (and the effect of CF mutations on NBDl structure) resembles that of CFTR. Login to comment
223 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:223:48
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:223:58
status: NEW
view ABCC7 p.Arg553Met details
Because wild-type phenotypes were observed with R553Q and R553M mutations alone, these mutations may be compensatory mutations that cause no detectable phenotype themselves. Login to comment
235 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:235:52
status: NEW
view ABCC7 p.Arg553Gln details
Interestingly, a CF patient with both the AF508 and R553Q mutations on the same chromosome has been described (Dork et al., 1991). Login to comment
236 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 7682896:236:51
status: NEW
view ABCC7 p.Arg553* details
On the non-AF508 chromosome, the nonsense mutation R553X was found. Login to comment
238 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 7682896:238:170
status: NEW
view ABCC7 p.Arg553* details
In contrast, the mean value for patients (n = 80) homozygous for the AF508 mutation in that clinic was 109 mmolll and was 86 mmolll for patients (n = 9) heterozygous for R553X and AF508; these values are characteristic of CF patients and significantly higher than the normal range. Login to comment
239 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:239:40
status: NEW
view ABCC7 p.Arg553Gln details
It is interesting to speculate that the R553Q mutation may partially suppress the AF508 Cl- transport defect in the sweat gland in this patient, but is unable to suppress the defect in other affected tissues, such as the lung and pancreas, sufficiently to prevent clinical disease. Login to comment
240 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:240:13
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:240:100
status: NEW
view ABCC7 p.Arg553Met details
Although the R553Q mutation corrected the defect in the P, of CFTRAF508, it was less effective than R553M in correcting the processing defect of CFTRAF508. Login to comment
241 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:241:32
status: NEW
view ABCC7 p.Arg553Gln details
Thus, the in vivo effect of the R553Q mutation on processing and function of CFTRAF508 might be quite small. Login to comment
242 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:242:137
status: NEW
view ABCC7 p.Arg553Gln details
However, a combination of restored CFTRAF508 channel function and improved processing might be sufficient to allow some of the CFTRAF508/R553Q mutant protein to reach the plasma membrane, where it could mediate Cl- transport in the duct of the sweat gland. Login to comment
243 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:243:72
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:243:43
status: NEW
view ABCC7 p.Arg553Met details
In this regard, one might predict that the R553M mutation (or the AF508/R553Q on both chromosomes) might have a greater effect in suppressing the AF508 Cl- transport defect in the sweat gland and other organs. Login to comment
275 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:275:55
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:275:65
status: NEW
view ABCC7 p.Arg553Met details
Two such colonies were identified (which contained the R553Q and R553M mutations), plasmid DNA was isolated from each, and the DNA sequence of the NED1 region was determined. Login to comment
284 ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:284:279
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Gln
X
ABCC7 p.Arg553Gln 7682896:284:314
status: NEW
view ABCC7 p.Arg553Gln details
ABCC7 p.Arg553Met
X
ABCC7 p.Arg553Met 7682896:284:299
status: NEW
view ABCC7 p.Arg553Met details
To express CFTR in HeLa cells transiently, cells were infected with recombinant vaccinia virus (vTF7-3) to express the T7 bacteriophage RNA polymerase and then transfected with plasmid DNA containing either wild-type CFTR (pTM-CFTR-4) or CFTR mutants (pTMCFTRAF508, pTMCFTRAF508/R553Q, pTMCFTRAF508/R553M, pTMCFTR/R553Q, and pTMCFTWR553M) under the control of the T7 promoter, essentially as described in Rich et al. (1990). Login to comment